Abstracts tagged "crystal-induced arthritis and ultrasound"

Abstract Number: 3198 • 2016 ACR/ARHP Annual Meeting
Inter-Reader and Intra-Reader Reliability of the New Omeract Ultrasonographic Criteria for the Diagnosis of Calcium Pyrophosphate Deposition Disease
Georgios Filippou¹, Carlo Alberto Scirè², Nemanja Damjanov³, Antonella Adinolfi⁴, Greta Carrara⁵, Valentina Picerno¹, Carmela Toscano¹, George A. W. Bruyn⁶, Maria Antonietta D'Agostino⁷, Andrea Delle Sedie⁸, Emilio Filippucci⁹, Marwin Gutierrez¹⁰, Mihaela Cosmina Micu¹¹, Ingrid Moller¹², Esperanza Naredo¹³, Pascal Zufferey¹⁴, Carlos Pineda¹⁵, francesco Porta¹⁶, Wolfgang A. Schmidt¹⁷, Lene Terslev¹⁸, Violeta Vlad¹⁹, Bruno Frediani¹, Annamaria Iagnocco²⁰ and OMERACT working group "US in CPPD", ¹University of Siena, Siena, Italy, ²Epidemiology Unit – Italian Society for Rheumatology (SIR), Milano, Italy, ³Institute of Rheumatology, University of Belgrade Medical School, Belgrade, Serbia, ⁴Policlinico le Scotte, Siena, Italy, ⁵Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy, ⁶Rheumatology, MC Groep, Loenga, Netherlands, ⁷University of Paris, Paris, France, ⁸Department Rheumatology, University of Pisa, Pisa, Italy, ⁹Clinica Reumatologica, Università Politecnica delle Marche, Jesi, Italy, ¹⁰Instituto Nacional de Rehabilitación, Mexico, Mexico, ¹¹Division of Rheumatology, Department of Rehabilitation II, Clinical Rehabilitation Hospital, Cluj Napoca, Romania, ¹²Direction, Poal Institute of Rheumatology, Corbera de Llobregat, Spain, ¹³Rheumatology, Hospital General Universitario Gregorio Marañón and Universidad Complutense, Madrid, Spain, ¹⁴Department of Rheumatology, University Hospital Lausanne, Lausanne, Switzerland, ¹⁵Instituto Nacional de Rehabilitation, Mexico, Mexico, ¹⁶Hospital of Pistoia, Pistoia, Italy, ¹⁷Immanuel Krankenhaus Berlin, Med Ctr for Rheumatology Berlin-Buch, Berlin, Germany, ¹⁸Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Copenhagen, Denmark, ¹⁹RCRD Research Center, Bucharest, Romania, ²⁰Sapienza Università di Roma, Roma, Italy
Background/Purpose: ultrasonography (US) has been implemented recently as a possible diagnostic method for CPPD[1]. However, data on the reliability of US in CPPD diagnosis are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].